Regulatory & Clinical
Decentralized Trials in 2026: Lessons from the Frontlines
How leading CROs and sponsors are implementing remote monitoring and hybrid trial designs at scale.
Search our curated directory of pharmaceutical companies, biotech firms, CROs, CDMOs, and service providers across 30+ countries.
OUR INSIGHTS & ARTICLES
Separating genuine machine learning advances in target identification from inflated expectations — an evidence-based assessment of where computational approaches are delivering real value in preclinical pipelines.
By Dr. Elena Gagliardi · 8 min read · March 2026
No articles found for this topic yet.
How leading CROs and sponsors are implementing remote monitoring and hybrid trial designs at scale.
Mapping the current gene therapy landscape — approved products, candidates, manufacturing bottlenecks.
IRA implications, European HTA reforms, and pricing frameworks reshaping commercial strategy.
Why continuous manufacturing is no longer optional and how leading facilities are making the transition.
Evaluating the regulatory and practical readiness of wearable-derived endpoints in pivotal studies.
From obesity to NASH to cardiovascular disease — the remarkable expansion of the GLP-1 class.
Why continuous manufacturing is no longer optional and how leading facilities are making the transition.
The premier gathering for the global pharmaceutical and life sciences ecosystem. One stage. Every discipline. Actionable science. Cross-disciplinary insights spanning discovery, regulation, manufacturing, and commercialization.
Whether you're interested in attending an upcoming conference, speaking at an event, sponsoring our platform, or joining our community, we'd love to hear from you.
+ 1 347 480 1588 (US)
+ 44 208 638 7213 (UK)
+ 91 813 004 7071 (IN)
pharma@theconferencegorilla.com
contact@theconferencegorilla.com
Global Headquarters
158 E 12300 S, Unit #621 Draper, UT 84020 Utah,
United States of America